269 related articles for article (PubMed ID: 24408965)
21. Mechanistic insights into mRNA 3'-end processing.
Kumar A; Clerici M; Muckenfuss LM; Passmore LA; Jinek M
Curr Opin Struct Biol; 2019 Dec; 59():143-150. PubMed ID: 31499460
[TBL] [Abstract][Full Text] [Related]
22. Cleavage factor Im is a key regulator of 3' UTR length.
Gruber AR; Martin G; Keller W; Zavolan M
RNA Biol; 2012 Dec; 9(12):1405-12. PubMed ID: 23187700
[TBL] [Abstract][Full Text] [Related]
23. Long-distance regulation of Add2 pre-mRNA3'end processing.
Nedeljkovic M; Costessi L; Iaconcig A; Porro F; Muro AF
RNA Biol; 2013 Apr; 10(4):516-27. PubMed ID: 23411391
[TBL] [Abstract][Full Text] [Related]
24. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.
Nemeroff ME; Barabino SM; Li Y; Keller W; Krug RM
Mol Cell; 1998 Jun; 1(7):991-1000. PubMed ID: 9651582
[TBL] [Abstract][Full Text] [Related]
25. A functional human Poly(A) site requires only a potent DSE and an A-rich upstream sequence.
Nunes NM; Li W; Tian B; Furger A
EMBO J; 2010 May; 29(9):1523-36. PubMed ID: 20339349
[TBL] [Abstract][Full Text] [Related]
26. THOC5 controls 3'end-processing of immediate early genes via interaction with polyadenylation specific factor 100 (CPSF100).
Tran DD; Saran S; Williamson AJ; Pierce A; Dittrich-Breiholz O; Wiehlmann L; Koch A; Whetton AD; Tamura T
Nucleic Acids Res; 2014 Oct; 42(19):12249-60. PubMed ID: 25274738
[TBL] [Abstract][Full Text] [Related]
27. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
28. Post-transcriptional control of neurofilaments in development and disease.
Thyagarajan A; Strong MJ; Szaro BG
Exp Cell Res; 2007 Jun; 313(10):2088-97. PubMed ID: 17428473
[TBL] [Abstract][Full Text] [Related]
29. Transcription termination downstream of the Saccharomyces cerevisiae FBP1 [changed from FPB1] poly(A) site does not depend on efficient 3'end processing.
Aranda A; Pérez-Ortín JE; Moore C; del Olmo ML
RNA; 1998 Mar; 4(3):303-18. PubMed ID: 9510332
[TBL] [Abstract][Full Text] [Related]
30. Assembly of the cleavage and polyadenylation apparatus requires about 10 seconds in vivo and is faster for strong than for weak poly(A) sites.
Chao LC; Jamil A; Kim SJ; Huang L; Martinson HG
Mol Cell Biol; 1999 Aug; 19(8):5588-600. PubMed ID: 10409748
[TBL] [Abstract][Full Text] [Related]
31. A plant-like mechanism coupling m6A reading to polyadenylation safeguards transcriptome integrity and developmental gene partitioning in
Farhat DC; Bowler MW; Communie G; Pontier D; Belmudes L; Mas C; Corrao C; Couté Y; Bougdour A; Lagrange T; Hakimi MA; Swale C
Elife; 2021 Jul; 10():. PubMed ID: 34263725
[TBL] [Abstract][Full Text] [Related]
32. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Identification of mRNA Polyadenylation Sites by PAPERCLIP.
Hwang HW; Darnell RB
Methods Mol Biol; 2017; 1648():79-93. PubMed ID: 28766291
[TBL] [Abstract][Full Text] [Related]
34. Proteasomal activity is required to initiate and to sustain translational activation of messenger RNA encoding the stem-loop-binding protein during meiotic maturation in mice.
Yang Q; Allard P; Huang M; Zhang W; Clarke HJ
Biol Reprod; 2010 Jan; 82(1):123-31. PubMed ID: 19759367
[TBL] [Abstract][Full Text] [Related]
35. Antisense targeting of 3' end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approach.
Marsollier AC; Ciszewski L; Mariot V; Popplewell L; Voit T; Dickson G; Dumonceaux J
Hum Mol Genet; 2016 Apr; 25(8):1468-78. PubMed ID: 26787513
[TBL] [Abstract][Full Text] [Related]
36. Ipa1 Is an RNA Polymerase II Elongation Factor that Facilitates Termination by Maintaining Levels of the Poly(A) Site Endonuclease Ysh1.
Pearson EL; Graber JH; Lee SD; Naggert KS; Moore CL
Cell Rep; 2019 Feb; 26(7):1919-1933.e5. PubMed ID: 30759400
[TBL] [Abstract][Full Text] [Related]
37. Tumor protein D52 expression is post-transcriptionally regulated by T-cell intercellular antigen (TIA) 1 and TIA-related protein via mRNA stability.
Motohashi H; Mukudai Y; Ito C; Kato K; Shimane T; Kondo S; Shirota T
Biochem J; 2017 May; 474(10):1669-1687. PubMed ID: 28298474
[TBL] [Abstract][Full Text] [Related]
38. Aberrant regulation of messenger RNA 3'-untranslated region in human cancer.
López de Silanes I; Quesada MP; Esteller M
Cell Oncol; 2007; 29(1):1-17. PubMed ID: 17429137
[TBL] [Abstract][Full Text] [Related]
39. Mos 3' UTR regulatory differences underlie species-specific temporal patterns of Mos mRNA cytoplasmic polyadenylation and translational recruitment during oocyte maturation.
Prasad CK; Mahadevan M; MacNicol MC; MacNicol AM
Mol Reprod Dev; 2008 Aug; 75(8):1258-68. PubMed ID: 18246541
[TBL] [Abstract][Full Text] [Related]
40. Systematic dissection of the sequence determinants of gene 3' end mediated expression control.
Shalem O; Sharon E; Lubliner S; Regev I; Lotan-Pompan M; Yakhini Z; Segal E
PLoS Genet; 2015 Apr; 11(4):e1005147. PubMed ID: 25875337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
